筛选条件 共查询到120条结果
排序方式
Gases for establishing pneumoperitoneum during laparoscopic abdominal surgery

期刊: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (3)

Background This is the second update of a Cochrane Review first published in 2013 and last updated in 2017. Laparoscopic surgery is now widely perform......

JIF:3.225

Percutaneous transluminal angioplasty and stenting for vertebral artery stenosis

期刊: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (5)

Background Vertebral artery stenosis (narrowing of the vertebral artery) is an important cause of posterior circulation ischaemic stroke. Medical trea......

JIF:3.225

Duct-to-mucosa versus other types of pancreaticojejunostomy for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy

期刊: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (3)

Background Postoperative pancreatic fistula is a common and serious complication following pancreaticoduodenectomy. Duct-to-mucosa pancreaticojejunost......

JIF:3.225

Chest physiotherapy for pneumonia in adults

期刊: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (9)

Background Despite conflicting evidence, chest physiotherapy has been widely used as an adjunctive treatment for adults with pneumonia. This is an upd......

JIF:3.225

Interventions for reducing inflammation in familial Mediterranean fever

期刊: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (3)

Background Familial Mediterranean fever (FMF), a hereditary auto-inflammatory disease, mainly aGects ethnic groups living in the Mediterranean region.......

JIF:3.225

Probiotics for the prevention of Hirschsprung-associated enterocolitis

期刊: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (4)

Background Hirschsprung-associated enterocolitis (HAEC) is a leading cause of serious morbidity and potential mortality in children with Hirschsprung'......

JIF:3.225

The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma

期刊: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (1)

Background Hepatocellular carcinoma is the sixth most common cancer worldwide. Hepatic resection is regarded as the curative therapy for hepatocellula......

JIF:3.225

Perioperative enhanced recovery programmes for women with gynaecological cancers

期刊: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (3)

Background Gynaecological cancers account for 15% of newly diagnosed cancer cases in women worldwide. In recent years, increasing evidence demonstrate......

JIF:3.225

Endovascular therapy versus medical treatment for spontaneous isolated dissection of the superior mesenteric artery

期刊: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (9)

Background Spontaneous isolated dissection of the superior mesenteric artery (SIDSMA) occurs when a tear in the inner layer of the superior mesenteric......

JIF:3.225

Calcium channel blockers versus other classes of drugs for hypertension

期刊: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (1)

Background This is the first update of a review published in 2010. While calcium channel blockers (CCBs) are often recommended as a first-line drug to......

JIF:3.225

Negative pressure wound therapy for managing the open abdomen in non-trauma patients

期刊: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (5)

Background Management of the open abdomen is a considerable burden for patients and healthcare professionals. Various temporary abdominal closure tech......

JIF:3.225

Medical methods for first trimester abortion

期刊: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (5)

Background Medical abortion became an alternative method of pregnancy termination following the development of prostaglandins and anti progesterone in......

JIF:3.225

Probiotics for preventing acute upper respiratory tract infections

期刊: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (8)

Background Probiotics are live micro-organisms that may give a beneficial physiological effect when administered in adequate amounts. Some trials show......

JIF:3.225

Ocrelizumab for multiple sclerosis

期刊: COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (5)

Background Ocrelizumab is a humanised anti-CD20 monoclonal antibody developed for the treatment of multiple sclerosis (MS). It was approved by the Foo......

JIF:3.225

共120条页码: 1/8页15条/页